OA08238A - Hepatitis B surface antigen formed by recombinant DNA techniques vaccines diagnostics cell lines and methods of forming same - Google Patents

Hepatitis B surface antigen formed by recombinant DNA techniques vaccines diagnostics cell lines and methods of forming same

Info

Publication number
OA08238A
OA08238A OA58835A OA58835A OA08238A OA 08238 A OA08238 A OA 08238A OA 58835 A OA58835 A OA 58835A OA 58835 A OA58835 A OA 58835A OA 08238 A OA08238 A OA 08238A
Authority
OA
OAPI
Prior art keywords
vaccines
hepatitis
methods
cell lines
recombinant dna
Prior art date
Application number
OA58835A
Inventor
John S Salstrom
Hans Thoma
Mark L Rohrbaugh
Original Assignee
Endotronics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Endotronics Inc filed Critical Endotronics Inc
Publication of OA08238A publication Critical patent/OA08238A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/61—Growth hormone [GH], i.e. somatotropin
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/576—Immunoassay; Biospecific binding assay; Materials therefor for hepatitis
    • G01N33/5761—Hepatitis B
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/576—Immunoassay; Biospecific binding assay; Materials therefor for hepatitis
    • G01N33/5761—Hepatitis B
    • G01N33/5764—Hepatitis B surface antigen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2730/00—Reverse transcribing DNA viruses
    • C12N2730/00011—Details
    • C12N2730/10011—Hepadnaviridae
    • C12N2730/10111—Orthohepadnavirus, e.g. hepatitis B virus
    • C12N2730/10122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Medicinal Chemistry (AREA)
  • Zoology (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Pathology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Wood Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Endocrinology (AREA)
  • Communicable Diseases (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Analytical Chemistry (AREA)
  • Plant Pathology (AREA)
  • Toxicology (AREA)
  • Virology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
OA58835A 1985-04-15 1986-04-15 Hepatitis B surface antigen formed by recombinant DNA techniques vaccines diagnostics cell lines and methods of forming same OA08238A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP85104521 1985-04-15
US85056786A 1986-04-11 1986-04-11

Publications (1)

Publication Number Publication Date
OA08238A true OA08238A (en) 1987-10-30

Family

ID=26096680

Family Applications (1)

Application Number Title Priority Date Filing Date
OA58835A OA08238A (en) 1985-04-15 1986-04-15 Hepatitis B surface antigen formed by recombinant DNA techniques vaccines diagnostics cell lines and methods of forming same

Country Status (9)

Country Link
KR (1) KR960004264B1 (en)
AU (1) AU606574B2 (en)
DK (1) DK171386A (en)
FI (1) FI95045C (en)
HU (1) HUT40699A (en)
NO (1) NO861450L (en)
NZ (1) NZ215820A (en)
OA (1) OA08238A (en)
PT (1) PT82392B (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR970007153B1 (en) * 1987-06-22 1997-05-03 메데바 홀딩스 비브이 Hepatitis b surface antigen vaccine

Also Published As

Publication number Publication date
PT82392B (en) 1988-03-03
DK171386A (en) 1986-10-16
HUT40699A (en) 1987-01-28
FI95045B (en) 1995-08-31
FI861559A (en) 1986-10-16
KR960004264B1 (en) 1996-03-30
FI95045C (en) 1995-12-11
NO861450L (en) 1986-10-16
PT82392A (en) 1986-05-01
NZ215820A (en) 1989-01-06
DK171386D0 (en) 1986-04-15
AU5611486A (en) 1986-10-23
KR860008284A (en) 1986-11-14
AU606574B2 (en) 1991-02-14
FI861559A0 (en) 1986-04-14

Similar Documents

Publication Publication Date Title
HK1003794A1 (en) Hepatitis b surface antigen formed by recombinant dna techniques vaccines diagnostic cell lines and methods of forming same
IL85216A0 (en) Hepatitis b virus surface antigens and hybrid antigens containing them
PH25249A (en) Method for producing hepatitis b virus proteins in yeast
IL69423A0 (en) Recombinant plasmid inserted with hepatitis b virus gene,yeast transformed with said recombinant plasmid and production of hepatitis b virus surface antigen
EP0105149A3 (en) Recombinant plasmid containing hepatitis b virus gene, yeast transformed with said recombinant plasmid, and production of hepatitis b virus surface antigen
DE3474775D1 (en) Method for purification of hepatitis b virus surface antigen
DE3378959D1 (en) Methods for preparation of hepatitis b surface antigen free gamma globulins and products
PT85137A (en) T and b cell epitopes of the pre-s region of hepatitis b virus surface antigen
EP0232410A4 (en) Lysis method and buffer for extraction of hepatitis b surface antigen from yeast cells.
ZA861767B (en) Process for preparing hepatitis b surface antigen containing particles in novel forms which are highly immunogenic
IL72452A0 (en) Method for the preparation of yeast chromatin and its use for obtaining antibodies for the detection of mammalian carcinomas
JPS54141790A (en) Modified dna and method of manufacturing hybrid protein using it
PT82392A (en) Hepatitis b surface antigen formed by recombinant dna techniques vaccines diagnostics cell lines and methods of forming same
DE3162469D1 (en) Method of growing hepatitis b surface antigen
GB2181434A (en) Hepatitis b virus vaccine and process for its preparation
ZA868612B (en) Lysis method and buffer for extraction of hepatitis b surface antigen from yeast cells
IL83670A0 (en) Dna coding for antigen protein of rinderpest virus and process for the preparation thereof
GR862721B (en) Lysis method and buffer for extraction of hepatitis b surface antigen from yeast cells
IE871644L (en) T and b cell epitopes of the pre-s region of hepatitis b¹virus surface antigen
SG139793G (en) Preparation of hepatitis B surface antigen in yeast.
ZA869516B (en) Method for producing selected polypeptides in virally infected insect cells and polypeptides isolated therefrom
IE852110L (en) Recombinant hepatitis antigen
ZA874498B (en) T and b cell epitopes of the pre-s region of hepatitis b virus surface antigen
IE861419L (en) Isolation of hepatitis b surface antigen
JPS645492A (en) Production of b type hepatitis virus protein in yeast